Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler

Asthma management guidelines recommend adding a long-acting β(2)-agonist (LABA) or increasing the dose of inhaled corticosteroid (ICS) as step-up therapy for patients with uncontrolled asthma on ICS monotherapy. However, it is uncertain which option works best, which ICS particle size is most effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, David B., Colice, Gene, Israel, Elliot, Roche, Nicolas, Postma, Dirkje S., Guilbert, Theresa W., van Aalderen, Willem M.C., Grigg, Jonathan, Hillyer, Elizabeth V., Thomas, Victoria, Martin, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005184/
https://www.ncbi.nlm.nih.gov/pubmed/27730200
http://dx.doi.org/10.1183/23120541.00106-2015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005184/
https://www.ncbi.nlm.nih.gov/pubmed/27730200
http://dx.doi.org/10.1183/23120541.00106-2015

Ejemplares similares